KPC Pharmaceuticals, Inc.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Kunyao Group Co., Ltd. (referred to as Kunyao Group 600422SH) was established in March 1951 and listed on the Shanghai Stock Exchange in December 2000. The company has profound professional pharmaceutical experience and is a national key high-tech enterprise and one of the top 100 enterprises in the Chinese pharmaceutical industry. Relying on the rich plant resources in Yunnan, Kunyao Group has successively developed more than 40 natural drug new products with advanced domestic and international levels, including Artemisia annua, Panax notoginseng, and Gastrodia elata, as well as characteristic traditional Chinese medicine and ethnic medicine. At the same time, it inherits the essence of traditional Chinese medicine and creates a batch of high-quality traditional Chinese medicine represented by Shenling Jianpi Stomach Granules, Shugan Granules, etc., gradually forming four core business patterns: chronic disease management, health consumption, overseas international, and beautiful health. At present, Kunyao Group has more than 50 participating holding companies, including Kunming Traditional Chinese Medicine Factory Co., Ltd. and Kunming Beck Norton Pharmaceutical Co., Ltd., as well as a large-scale intelligent manufacturing center, Xuesaitong Pharmaceutical Research Institute, and postdoctoral workstations. The company has over 30 years of overseas expansion experience in artemisinin business, and its product sales network covers more than 60 countries worldwide. In December 2022, China Resources 39 completed the acquisition of a portion of the equity of Kunming Pharmaceutical Group, becoming the largest shareholder of Kunming Pharmaceutical. In the future, Kunyao will aim to "become the first stock of silver haired economy and health, a leader in chronic disease management, and a leader in high-quality Chinese medicine", assist in the upgrading and development of the traditional Chinese medicine industry, continuously promote the inheritance and innovation of traditional Chinese medicine, and practice the responsibility and responsibility of state-owned enterprises with performance. |
| Headquarter | Kunming |
| Establish Date | 12/14/1995 |
| Listed Code | 600422.SH |
| Listed Date | 12/6/2000 |
| Chairman | Qiu Huawei. |
| CEO | Yan Wei. |
| Website | www.kpc.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
